In particular, the authors showed that lower levels of RKIP in metastatic breast tumours depress the expression of the inhibitory microRNA miR185 and, consequently, increase HMGA2 that, in turn, sustains malignancy and invasiveness of cancer cells. The gene discussed is PEBP1; the disease is breast neoplasm.